Selective Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Selective Wealth Management's BMY Position: Q4 2025 in Review
Selective Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 4,600 shares — an estimated $205K sold.
Selective Wealth Management first reported a position in BMY in Q3 2018 and held it in 25 quarters. The position peaked at $4.27M in Q4 2020. 2,448 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Selective Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Selective Wealth Management sold 4,600 Bristol-Myers Squibb shares in Q4 2025, an estimated $205K.
- Selective Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2018 and held it in 25 quarters.
- Selective Wealth Management's Bristol-Myers Squibb position peaked at $4.27M in Q4 2020.
- 2,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Selective Wealth Management's 13F filing for Q4 2025, filed 16 Jan 2026.